TrialPain practice : the official journal of World Institute of Pain2019

APOLLO-2: A Randomized, Placebo and Active-Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein-Biased Ligand at the μ-Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty.

Neil K Singla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.